Therapeutic targeting of autophagy in cardiovascular disease. (June 2016)

• Record Type: Journal Article
• Authors: Schiattarella, Gabriele G.; Hill, Joseph A.
• Is Part Of: Journal of molecular and cellular cardiology. Volume 95(2016:Jun.)
• Page Start: 86
• Page End: 93
• Publication Date: 2016-06
• Subjects: Cardiac hypertrophy -- Heart failure -- Remodeling; Cardiology -- Periodicals; Heart Diseases -- Periodicals; Molecular Biology -- Periodicals; Cardiologie -- Périodiques; Cardiology; Electronic journals; Periodicals; 616.12
• DOI: 10.1016/j.yjmcc.2015.11.019
• Languages: English
• ISSNs: 0022-2828

Abstract

Abstract: Autophagy is an evolutionarily ancient process of intracellular catabolism necessary to preserve cellular homeostasis in response to a wide variety of stresses. In the case of post-mitotic cells, where cell replacement is not an option, finely tuned quality control of cytoplasmic constituents and organelles is especially critical. And due to the ubiquitous and critical role of autophagic flux in the maintenance of cell health, it comes as little surprise that perturbation of the autophagic process is observed in multiple disease processes. A large body of preclinical evidence suggests that autophagy is a double-edged sword in cardiovascular disease, acting in either beneficial or maladaptive ways, depending on the context. In light of this, the autophagic machinery in cardiomyocytes and other cardiovascular cell types has been proposed as a potential therapeutic target. Here, we summarize current knowledge regarding the dual functions of autophagy in cardiovascular disease. We go on to analyze recent evidence suggesting that titration of autophagic flux holds potential as a novel treatment strategy. Highlights: Autophagy is an intracellular process required to maintain cardiovascular homeostasis. Perturbations in autophagy are involved in virtually all cardiovascular disease states. Depending on the context, autophagic flux may be biased up or down. Autophagy mediators hold promise as targets for cardiovascular disease therapy.